Prevalence of Comorbidities Among Pediatric Patients With Hidradenitis Suppurativa: A Meta-Analysis

Samiha T Mohsen1, Emma L Price2, Irene Lara-Corrales3

  • 1University of Toronto, Toronto, Ontario, Canada.

JAMA Dermatology
|June 11, 2025
PubMed

Insights

Pediatric patients with hidradenitis suppurativa (HS) frequently experience comorbidities like obesity and anxiety. Early identification and a multidisciplinary approach are crucial for managing this chronic inflammatory skin condition.

Area of Science:

  • Dermatology
  • Pediatrics
  • Public Health

Background:

  • Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease affecting pediatric patients.
  • Pediatric HS is associated with significant comorbidities, impacting quality of life.

Purpose of the Study:

  • To evaluate the association between pediatric HS and comorbidities.
  • To determine the pooled prevalence of comorbidities in pediatric HS patients.

Main Methods:

  • Searched Embase, PubMed/MEDLINE, and Cochrane Central Register.
  • Included original investigations on pediatric HS and comorbidities; performed meta-analyses of proportions.
  • Assessed evidence certainty using the GRADE approach.

Main Results:

  • Included 19 studies with 17,267 pediatric HS patients.
  • Prevalent comorbidities: acne vulgaris (43%), obesity (37%), anxiety (18%), hirsutism (14%).
  • Moderate certainty for HS with obesity/depression; low certainty for HS with diabetes.

Conclusions:

  • Pediatric HS is linked to increased prevalence of chronic medical and psychiatric comorbidities.
  • A multidisciplinary approach is recommended for managing pediatric HS and its associated conditions.
Abstract